Intrinsiqq
Sellas Life Sciences Group Inc. logo

Sellas Life Sciences Group Inc. Intrinsic Value

SLS

⊜ Compare

Sellas Life Sciences Group fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Sellas Life Sciences Group today, so there is nothing to project yet.

Peers

Pharmaceutical Preparations · Pick stocks to compare with SLS

CompareIntrinsic value
MREOMereo BioPharma Group plc
$0.29-3.97%10
COYACoya Therapeutics Inc.
$3.61-9.30%10
PRLDPrelude Therapeutics Incorporated
$3.88-5.37%40
PLRXPliant Therapeutics Inc.
$0.86-0.13%10
AARDAardvark Therapeutics, Inc.
$1.36-5.56%10
ORMPOramed Pharmaceuticals Inc.
$4.11-2.84%35
NTHINeonC Technologies Holdings
$3.26+4.49%10
SLNSilence Therapeutics plc
$19.75-0.25%10

Held by ETFs

SLS is in 33 US ETFs. The largest of them, with SLS's weight in each:

Spot a number that looks wrong? Check it in SLS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SLS

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.